Are histomorphological patterns a predictor for survival in uveal melanoma patients with hepatic metastases undergoing hepatic artery infusion chemotherapy?

被引:0
作者
Steinberg-Vorhoff, Hannah L. [1 ]
Ting, Saskia C. [2 ]
Zensen, Sebastian [1 ]
Ludwig, Johannes M. [3 ]
Li, Yan [1 ]
Richly, Heike [4 ]
Grueneisen, Johannes [1 ]
Siveke, Jens T. [5 ,6 ,7 ]
Theysohn, Jens M. [1 ]
Schaarschmidt, Benedikt M. [1 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany
[2] Univ Hosp Essen, Inst Pathol, Essen, Germany
[3] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Radiol & Nucl Med, Mannheim, Germany
[4] Univ Duisburg Essen, Sarcoma Ctr, West German Canc Ctr, Dept Med Oncol, Essen, Germany
[5] Univ Hosp Essen, West German Canc Ctr, Inst Dev Canc Therapeut, Essen, Germany
[6] German Canc Consortium DKTK, Div Solid Tumor Translat Oncol, Partner Site Essen, Heidelberg, Germany
[7] German Canc Res Ctr, DKFZ, German, Heidelberg, Germany
关键词
HAIC; hepatic artery infusion therapy; histomorphological pattern; prognosis; survival; CALLENDER CLASSIFICATION; LIVER METASTASES; DISEASE; INTRAARTERIAL; FOTEMUSTINE; EXPERIENCE; PROGNOSIS; FAILURE; BENEFIT; TRENDS;
D O I
10.1111/1754-9485.13783
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction:<bold> </bold>In uveal melanoma (UM) patients with hepatic metastases, hepatic artery infusion chemotherapy (HAIC) is a viable, palliative treatment option. To evaluate the impact of two histomorphological patterns (spindle cell vs. epithelioid) of liver metastases on median overall survival (mOS) in UM patients undergoing HAIC. Methods:<bold> </bold>A retrospective analysis with 60 UM patients (29 females, mean age: 61.6 +/- 12.1 years) with hepatic metastases was performed. Histomorphological patterns in metastases were analysed and classified as either predominant spindle cell or epithelioid pattern. mOS between both patient groups was analysed using Kaplan-Meier curves and the log-rank test. Results:<bold> </bold>In 73.3% (44/60) of the metastases, a predominant epithelioid pattern, in 21.7% (13/60) a predominant spindle cell pattern, and in 5% (3/60) other patterns were found. No significant differences between patients with an epithelioid (mOS: 14.2 months, 95% CI: 8.8-19.6) and a spindle cell pattern (mOS: 14.4 months, 95% CI: 4.3-24.5) were detected by the log-rank test, chi(2)(2) = 0.22, P = 0.881. Conclusion:<bold> </bold>Histomorphological patterns of UM metastases do not seem to be a predictor for mOS in UM patients undergoing HAIC.
引用
收藏
页码:862 / 869
页数:8
相关论文
共 50 条
  • [1] Radiation Dose Aspects of Hepatic Artery Infusion Chemotherapy in Uveal Melanoma Patients with Liver Metastases
    Zensen, Sebastian
    Opitz, Marcel K.
    Ludwig, Johannes M.
    Haubold, Johannes
    Richly, Heike
    Siveke, Jens T.
    Theysohn, Jens M.
    Forsting, Michael
    Bos, Denise
    Schaarschmidt, Benedikt M.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 45 (06) : 841 - 845
  • [2] Liver volumetry improves evaluation of treatment response to hepatic artery infusion chemotherapy in uveal melanoma patients with liver metastases
    Zensen, Sebastian
    Steinberg-Vorhoff, Hannah L.
    Milosevic, Aleksandar
    Richly, Heike
    Siveke, Jens T.
    Opitz, Marcel
    Haubold, Johannes
    Li, Yan
    Forsting, Michael
    Schaarschmidt, Benedikt Michael
    RADIOLOGY AND ONCOLOGY, 2024, 58 (04) : 509 - 516
  • [3] Transarterial Hepatic Chemoperfusion of Uveal Melanoma Metastases: Survival and Response to Treatment
    Heusner, T. -A.
    Antoch, G.
    Wittkowski-Sterczewski, A.
    Ladd, S. C.
    Forsting, M.
    Verhagen, R.
    Scheulen, M.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2011, 183 (12): : 1151 - 1160
  • [4] Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver Metastases
    Ludwig, Johannes
    Haubold, Johannes
    Heusner, Till-Alexander
    Bauer, Sebastian
    Siveke, Jens T.
    Richly, Heike
    Wetter, Axel
    Umutlu, Lale
    Theysohn, Jens M.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2021, 193 (06): : 683 - 691
  • [5] Locoregional Therapies for the Treatment of Uveal Melanoma Hepatic Metastases
    Gonsalves, Carin F.
    Adamo, Robert D.
    Eschelman, David J.
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2020, 37 (05) : 508 - 517
  • [6] Radioembolization as Locoregional Therapy of Hepatic Metastases in Uveal Melanoma Patients
    Klingenstein, A.
    Haug, A. R.
    Zech, C. J.
    Schaller, U. C.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 36 (01) : 158 - 165
  • [7] Immunoembolization for the Treatment of Uveal Melanoma Hepatic Metastases
    Gonsalves, Carin F.
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2024, 41 (01) : 20 - 26
  • [8] Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma
    Choudhary, Maria M.
    Gupta, Akshay
    Bena, James
    Emch, Todd
    Singh, Arun D.
    JAMA OPHTHALMOLOGY, 2016, 134 (02) : 174 - 180
  • [9] Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma
    Boone, Brian A.
    Perkins, Samantha
    Bandi, Rupal
    Santos, Ernesto
    McCluskey, Kevin
    Bartlett, David L.
    Pingpank, James F.
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (05) : 940 - 946
  • [10] MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients
    Marshall, Ernie
    Romaniuk, Christopher
    Ghaneh, Paula
    Wong, Helen
    McKay, Marie
    Chopra, Mona
    Coupland, Sarah E.
    Damato, Bertil E.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (02) : 159 - 163